Efficacy and Safety of Lidocaine Infusion Treatment for Neuropathic Pain: A Randomized, Double-Blind, and Placebo-Controlled Study
Conclusions
Lidocaine infusion therapy (3 mg/kg of lidocaine administered over 1 hour) provided effective short-term pain relief, which was substantially prominent after repeated infusions were administered to patients with refractory NeP.
Clinical Trial Registration
This study was registered at ClinicalTrials.gov, identifier NCT02597257.
Source: Regional Anesthesia and Pain Medicine - Category: Anesthesiology Tags: Chronic and Interventional Pain: Original Articles Source Type: research
More News: Anesthesia | Anesthesiology | Brain | Chronic Pain | Clinical Trials | Complex Regional Pain Syndrome | Lidoderm | Neurology | Pain | Study